Filings
Finds words inside filing documents. Searching Zymeworks Inc.'s filings · 53 documents indexed.
23 documents · 75 matches
-
ZYME Zymeworks Inc. 10-Q 2026-11-09
Item 1A. Risk Factors.
tariff measures. Additional tariffs have been recently imposed under Section 232 and Section 301 tariff measures, and additional trade-related8 matches in this document -
ZYME Zymeworks Inc. 10-Q 2026-08-06
Item 1A. Risk Factors.
tariff measures. Additional tariffs have been recently imposed under Section 232 and Section 301 tariff measures, and additional trade-related8 matches in this document -
ZYME Zymeworks Inc. 10-Q 2026-05-07
Item 1A. Risk Factors.
tariff measures. Additional tariffs have been recently imposed under Section 232 and Section 301 tariff measures, and additional trade-related8 matches in this document -
ZYME Zymeworks Inc. 10-K 2026-03-02
Item 1A. Risk Factors.
tariff measures. For example, additional tariffs have been recently imposed under Section 232 and Section 301 tariff measures, and additional8 matches in this document -
ZYME Zymeworks Inc. 10-Q 2025-11-06
Item 1A. Risk Factors.
tariffs on a number of countries. These include new global tariffs affecting virtually all U.S. trading partners, plus additional tariff9 matches in this document -
ZYME Zymeworks Inc. 10-Q 2025-08-07
Item 1A. Risk Factors.
tariffs on a number of countries. These include new global tariffs affecting virtually all U.S. trading partners, plus additional tariff9 matches in this document -
ZYME Zymeworks Inc. 10-Q 2025-05-08
Item 1A. Risk Factors.
tariffs on a number of countries, including China. The current U.S. Presidential administration has directed various federal agencies to further9 matches in this document -
ZYME Zymeworks Inc. 8-K 2026-11-09
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-10-23
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-08-06
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-06-29
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-06-29
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-05-14
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-05-07
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-04-01
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-03-02
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-03-02
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-01-12
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2026-01-12
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document -
ZYME Zymeworks Inc. 8-K 2025-11-18
tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal1 match in this document
Page 1 of 2 · 23 documents